KRAS and colorectal carcinoma: Similarly, the KRAS p.Gly12Val (G12V) mutation, other p.Gly12 mutations, and the p.Gly13Asp (G13D) mutation were each associated with significantly increased likelihoods of right-sided CRC: 134%, 191%, and 221% higher, respectively.